Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04644289
Title WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC (WoO)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AGO Research GmbH
Indications

ovarian cancer

Therapies

Olaparib

Durvalumab + Olaparib

Age Groups: adult
Covered Countries DEU


No variant requirements are available.